Complement. Second of two parts. [N Engl J Med. 2001]

SearchDatabase nameforSearch term

Your browser version may not work well with NCBI's Web applications. More information here...

Display Show

All: 1

1: N Engl J Med. 2001 Apr 12;344(15):1140-4. Links

Complement. Second of two parts.

Division of Medicine, Imperial College of Science, Technology and Medicine, London, United Kingdom. m.walport@ic.ac.uk

PMID: 11297706 [PubMed - indexed for MEDLINE]

APOMAB, a La-specific monoclonal antibody, detects the apoptotic tumor response to life-prolonging and DNA-damaging chemotherapy.
Al-Ejeh F, Darby JM, Tsopelas C, Smyth D, Manavis J, Brown MP. PLoS One. 2009; 4(2):e4558. Epub 2009 Feb 27.

[PLoS One. 2009]
Chemotherapy synergizes with radioimmunotherapy targeting La autoantigen in tumors.
Al-Ejeh F, Darby JM, Brown MP. PLoS One. 2009; 4(2):e4630. Epub 2009 Feb 27.

[PLoS One. 2009]
Identification of the high affinity binding site in the Streptococcus intermedius toxin intermedilysin for its membrane receptor, the human complement regulator CD59.
Hughes TR, Ross KS, Cowan GJ, Sivasankar B, Harris CL, Mitchell TJ, Morgan BP. Mol Immunol. 2009 Apr; 46(7):1561-7. Epub 2009 Feb 6.

[Mol Immunol. 2009]
» See all...

Your browsing activity is empty.

Activity recording is turned off.

Display Show